首页> 外国专利> METHOD FOR PREDICTING THE RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN THE NEXT 12 MONTHS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A COMBINATION WITH EARLY STAGES OF CHRONIC RENAL DISEASE

METHOD FOR PREDICTING THE RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN THE NEXT 12 MONTHS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A COMBINATION WITH EARLY STAGES OF CHRONIC RENAL DISEASE

机译:预测慢性阻塞性肺疾病合并早期慢性肾脏病的患者未来12个月内发生心血管并发症的风险的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely pulmonology, and can be used to predict the risk of developing cardiovascular complications in next 12 months in patients with chronic obstructive pulmonary disease combined with early stages of chronic renal disease. Sum of points is calculated on the PROCAM scale. If the total PROCAM (K) score is less than 56, a low risk of developing cardiovascular complications in next 12 months is stated. If K is more than 56, the level of vitamin D (VD), the glomerular filtration rate (GFR) and the number of exacerbations of chronic obstructive pulmonary disease (ECOPD) in the previous year are additionally determined. If K is more than 56 and GFR is less than 80 ml/min/1.73 m2 low risk of developing cardiovascular complications in next 12 months is determined. If K is more than 56 and VD is less than 34.3 ng/ml, K is more than 56 and ECOPD is more than 2, if K is more than 56 and GFR is less than 80 ml/min/1.73 m2 and the VD value less than 34.3 ng/ml, with K more than 56 and ECOPD greater than 2 and the VD value less than 34.3 ng/ml, high risk of developing cardiovascular complications.;EFFECT: method provides predicting the risk of developing cardiovascular complications in next 12 months in patients with chronic obstructive pulmonary disease combined with early stages of chronic renal disease by assessing the contribution of each predictor of developing cardiovascular complications.;1 cl, 2 tbl, 3 ex
机译:技术领域本发明涉及医学,即肺病学,并且可以用于预测慢性阻塞性肺疾病合并早期慢性肾脏病患者在未来12个月内发生心血管并发症的风险。点的总和以PROCAM标尺计算。如果总PROCAM(K)得分小于56,则表明在接下来的12个月内发生心血管并发症的风险较低。如果K大于56,则还要另外确定上一年的维生素D(VD),肾小球滤过率(GFR)和慢性阻塞性肺疾病加重次数(ECOPD)。如果K大于56并且GFR小于80 ml / min / 1.73 m 2 ,则可以确定在接下来的12个月内发生心血管并发症的风险较低。如果K大于56且VD小于34.3 ng / ml,则K大于56且ECOPD大于2,如果K大于56且GFR小于80 ml / min / 1.73 m 2 且VD值小于34.3 ng / ml,K大于56且ECOPD大于2,VD值小于34.3 ng / ml,发生心血管并发症的风险较高。通过评估每种发展心血管并发症的预测因素的贡献,在慢性阻塞性肺疾病合并慢性肾脏病早期阶段的患者中,在未来12个月内发生心血管并发症的风险。1cl,2 tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号